PremiumCompany AnnouncementsJPMorgan Becomes Substantial Holder in Mesoblast Limited Mesoblast Limited Announces Substantial Holding Update Is MEOBF a Buy, Before Earnings? PremiumCompany AnnouncementsState Street Corporation Ceases Substantial Holding in Mesoblast Limited Mesoblast Limited Announces New Substantial Holder Mesoblast Expands U.S. Market with Ryoncil® Launch and Advances Other Therapies PremiumThe FlyMesoblast extends payer coverage for Ryoncil to over 100M U.S. lives Mesoblast Limited Announces Cessation of Securities Mesoblast Limited Issues Over 8 Million New Securities